Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Attempting to change Delaware Corporate Law

Attempting to change Delaware Corporate Law

posted on Jan 30, 2010 03:32PM

does not a legitimate proposal make:

“restore coherence and clarity to this area of our law, we hold that the scope of the shareholder ratification doctrine must be limited to its so-called ‘classic’ form; that is, to circumstances where a fully informed shareholder vote approves director action that does not legally require shareholder approval in order to become legally effective. Moreover the only director action or conduct that can be ratified is that which the shareholders are specifically asked to approve. With one exception, the “cleansing” effect of such a ratifying shareholder vote is to subject the challenged director action to business judgment review, as opposed to “extinguishing” the claim altogether (i.e., obviating all judicial review of the challenged action.) "

In Gantler v. Stephens, (Del. Supr., Jan. 27, 2009)

.

It is now obvious why there has been no shareholder-led proxy solicitation.

.

.

Be well

Share
New Message
Please login to post a reply